High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

Hung-Chin Tsai,1–3 I-Tzu Chen,1 Kuan-Sheng Wu,1,2 Yu-Ting Tseng,1 Cheng-Len Sy,1 Jui-Kuang Chen,1 Susan Shin-Jung Lee,1,2 Yao-Shen Chen1,2 1Department of Medicine, Division of Infectious Diseases, Kaohsiung Veterans General Hospital, Kaohsiung, 2Faculty of Medicine, School of Medicine, Nat...

Full description

Bibliographic Details
Main Authors:	Tsai HC, Chen IT, Wu KS, Tseng YT, Sy CL, Chen JK, Lee SS, Chen YS
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-10-01
Series:	Infection and Drug Resistance
Subjects:	HIV drug resistance treatment failure
Online Access:	https://www.dovepress.com/high-rate-of-hiv-1-drug-resistance-in-treatment-failure-patients-in-ta-peer-reviewed-article-IDR

Similar Items

HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan
by: Tsai HC, et al.
Published: (2018-08-01)

HIV Drug Resistance after Failure of 6 Month First-line Therapy in a Hospital: A Case Series
by: Ardiana Kusumaningrum, et al.
Published: (2019-11-01)

Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran
by: Molood FARROKHI, et al.
Published: (2017-09-01)

HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis
by: Aklilu Endalamaw, et al.
Published: (2020-01-01)

Primary HIV Infection Presenting as Non-traumatic Rhabdomyolysis with Acute Renal Failure
by: Prabahar Murugesan, et al.
Published: (2008-01-01)

Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia
by: Gizachew Ayele, et al.
Published: (2018-12-01)

Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study
by: Dan Yuan, et al.
Published: (2020-06-01)

Determinants of Virological Failure Among Patients on First-line Antiretroviral Therapy in Central Oromia, Ethiopia: A Case–Control Study
by: Abdullahi IJ, et al.
Published: (2020-12-01)

Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis
by: Yishak Lailulo, et al.
Published: (2020-12-01)

Age at Diagnosis of Heart Failure in United States Veterans With and Without HIV Infection
by: Sebhat Erqou, et al.
Published: (2021-06-01)

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
by: Spagnuolo V, et al.
Published: (2019-01-01)

Failure to return to receive HIV-test results: the Cameroon experience
by: Defo Defo, et al.
Published: (2017-07-01)

HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients
by: Elmi Abar Aden, et al.
Published: (2012-10-01)

Characterization of virologic failure after an initially successful 48-week course of antiretroviral therapy in HIV/AIDS outpatients treated in Santos, Brazil
by: Marcos M. Caseiro, et al.

Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study
by: Sabin Nsanzimana, et al.
Published: (2019-04-01)

Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion
by: Shui-Shan Lee, et al.
Published: (2020-05-01)

Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy
by: Shanfang Qin, et al.
Published: (2021-05-01)

Antiretroviral Treatment Failure and Associated Factors Among HIV-Infected Children on Antiretroviral Therapy: A Retrospective Study
by: Getawa S, et al.
Published: (2021-02-01)

First line antiretroviral treatment failure and second line treatment outcomes among HIV patients in Southern Africa
by: Rohr, Julia Katherine
Published: (2016)

Increased Virological Failure and Determinants Among HIV Patients on Highly Active Retroviral Therapy in Adigrat General Hospital, Northern Ethiopia, 2019: Hospital-Based Cross-Sectional Study
by: Negash H, et al.
Published: (2020-06-01)

Prevalence of HIV-1 Integrase Strand Transfer Inhibitor Resistance in Treatment-Naïve Voluntary Counselling and Testing Clients by Population Sequencing and Illumina Next-Generation Sequencing in Taiwan
by: Tsai HC, et al.
Published: (2020-12-01)

HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014–2019
by: Lan Y, et al.
Published: (2021-08-01)

Determinants of Virological Failure Among Adult Clients on First-Line Antiretroviral Therapy in Amhara Regional State, Northeast Ethiopia. A Case –Control Study
by: Fentaw Z, et al.
Published: (2020-11-01)

Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study
by: Bayu B, et al.
Published: (2017-08-01)

Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration
by: Suzanne M. Ingle, et al.
Published: (2018-10-01)

First-Line Antiretroviral Regimen Failure and Determinants in an Urban HIV Clinic at Phramongkutklao Hospital, Bangkok, Thailand: 20 Years Experience
by: Nasomsong W, et al.
Published: (2021-03-01)

Elevation of immunoglobulin levels is associated with treatment failure in HIV-infected children in Vietnam
by: Dang LVP, et al.
Published: (2018-12-01)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
by: Phasomsap Chayapa, et al.
Published: (2011-10-01)

Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia
by: Gelila Solomon Haile, et al.
Published: (2019-01-01)

Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia
by: Yihienew Mequanint Bezabih, et al.
Published: (2019-06-01)

HIV Drug Resistance among Patients Failing Therapy at a Tertiary Center in Oman: A Case Record Review
by: Omaira Al-Omairi, et al.
Published: (2019-11-01)

Abortions followed by contraceptive failures in Northern India: an analysis of contraceptive histories (2009–2014)
by: Anjali Singh, et al.
Published: (2020-06-01)

Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique
by: Andrea De Luca, et al.
Published: (2017-09-01)

HIV infection and the kidneys, Part I
by: Basta-Jovanović Gordana
Published: (2005-01-01)

Determinants of immunological failure among clients on the first line treatment with highly active antiretroviral drugs in Dar es Salaam, Tanzania
by: Anthony Kapesa, et al.
Published: (2014-07-01)

Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
by: Jonathan Izudi, et al.
Published: (2016-10-01)

COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015
by: O. V. Reshetko, et al.
Published: (2018-03-01)

Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study
by: Chilot Desta Agegnehu, et al.
Published: (2020-07-01)

The social stigma of HIV–AIDS: society's role
by: Kontomanolis EN, et al.
Published: (2017-05-01)

Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?
by: Christine Gilles, et al.
Published: (2021-07-01)